Treatment of multiple sclerosis: current concepts and future perspectives
D Buck, B Hemmer - Journal of neurology, 2011 - Springer
Currently, several disease-modifying therapies for the treatment of multiple sclerosis are
established and more are likely to be introduced. These treatment options differ with respect …
established and more are likely to be introduced. These treatment options differ with respect …
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm
BAC Cree, J Mares, HP Hartung - Current opinion in neurology, 2019 - journals.lww.com
Current therapeutic landscape in multiple sclerosis: an evol... : Current Opinion in
Neurology Current therapeutic landscape in multiple sclerosis: an evolving treatment …
Neurology Current therapeutic landscape in multiple sclerosis: an evolving treatment …
Recent developments in multiple sclerosis therapeutics
RI Spain, MH Cameron, D Bourdette - BMC medicine, 2009 - Springer
Multiple sclerosis, the most common neurologic disorder of young adults, is traditionally
considered to be an inflammatory, autoimmune, demyelinating disease of the central …
considered to be an inflammatory, autoimmune, demyelinating disease of the central …
Update on disease-modifying therapies for multiple sclerosis
DL Vargas, WR Tyor - Journal of Investigative Medicine, 2017 - journals.sagepub.com
Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous
system (CNS). It predominantly affects young women and is one of the most common causes …
system (CNS). It predominantly affects young women and is one of the most common causes …
Future treatment approaches to multiple sclerosis
J Derwenskus, FD Lublin - Handbook of Clinical Neurology, 2014 - Elsevier
The modern treatment era for multiple sclerosis (MS) began in 1993 with the approval of the
first disease-modifying agent. Since then the field has greatly expanded, with 10 therapies …
first disease-modifying agent. Since then the field has greatly expanded, with 10 therapies …
Multiple sclerosis—a quiet revolution
RM Ransohoff, DA Hafler, CF Lucchinetti - Nature Reviews Neurology, 2015 - nature.com
Multiple sclerosis (MS) has been thought to be a complex and indecipherable disease, and
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …
The future of multiple sclerosis therapy
Multiple sclerosis (MS) represents the prototypic inflammatory autoimmune disorder of the
central nervous system and the most common cause of neurological disability in young …
central nervous system and the most common cause of neurological disability in young …
Established and novel disease‐modifying treatments in multiple sclerosis
AH Cross, RT Naismith - Journal of internal medicine, 2014 - Wiley Online Library
Multiple sclerosis (MS) is a presumed autoimmune disorder of the central nervous system,
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
resulting in inflammatory demyelination and axonal and neuronal injury. New diagnostic …
Disease modification in multiple sclerosis: an update
CM Rice - Practical neurology, 2014 - pn.bmj.com
Although there has been unequivocal progress in the development of treatments for multiple
sclerosis over the last 20 years, currently licensed treatments have demonstrated convincing …
sclerosis over the last 20 years, currently licensed treatments have demonstrated convincing …
New and emerging disease modifying therapies for multiple sclerosis
S Saidha, C Eckstein… - Annals of the New York …, 2012 - Wiley Online Library
Several disease‐modifying drugs (DMDs) are currently approved for the treatment of
multiple sclerosis (MS). Recently, there has been increased identification and development …
multiple sclerosis (MS). Recently, there has been increased identification and development …